These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6345399)

  • 1. Isolation and characterization of monoclonal antibodies to Shiga toxin.
    Griffin DE; Gentry MK; Brown JE
    Infect Immun; 1983 Jul; 41(1):430-3. PubMed ID: 6345399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin.
    Islam MS; Stimson WH
    J Clin Lab Immunol; 1990 Sep; 33(1):11-6. PubMed ID: 1966939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
    Brown JE; Griffin DE; Rothman SW; Doctor BP
    Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondal G; Faruque SM; Albert MJ
    Adv Exp Med Biol; 1995; 371B():923-6. PubMed ID: 7502927
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli.
    Strockbine NA; Marques LR; Holmes RK; O'Brien AD
    Infect Immun; 1985 Dec; 50(3):695-700. PubMed ID: 3905611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.
    O'Brien AD; Laveck GD
    Infect Immun; 1982 Mar; 35(3):1151-4. PubMed ID: 7040247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.
    Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M
    J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
    Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT
    Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B.
    Griffin DE; Gemski P
    Infect Immun; 1983 Apr; 40(1):425-8. PubMed ID: 6299964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
    Padhye VV; Zhao T; Doyle MP
    J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay for shigella toxin.
    Donohue-Rolfe A; Kelley MA; Bennish M; Keusch GT
    J Clin Microbiol; 1986 Jul; 24(1):65-8. PubMed ID: 3522627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of stx, a determinant essential for high-level production of shiga toxin by Shigella dysenteriae serotype 1, near pyrF and generation of stx transposon mutants.
    Sekizaki T; Harayama S; Brazil GM; Timmis KN
    Infect Immun; 1987 Sep; 55(9):2208-14. PubMed ID: 3040592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses.
    Su GF; Brahmbhatt HN; Wehland J; Rohde M; Timmis KN
    Infect Immun; 1992 Aug; 60(8):3345-59. PubMed ID: 1639503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay.
    Perera LP; Marques LR; O'Brien AD
    J Clin Microbiol; 1988 Oct; 26(10):2127-31. PubMed ID: 3053764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential virulence of viable but nonculturable Shigella dysenteriae type 1.
    Rahman I; Shahamat M; Chowdhury MA; Colwell RR
    Appl Environ Microbiol; 1996 Jan; 62(1):115-20. PubMed ID: 8572688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic peptides of Shiga toxin B-subunit induce antibodies which neutralize the biological activities of the toxin.
    Harari I; Donohue-Rolfe A; Keusch GT; Arnon R
    Ann Sclavo Collana Monogr; 1986; 3(1-2):125-30. PubMed ID: 3322336
    [No Abstract]   [Full Text] [Related]  

  • 20. Secretory immunoglobulin A response to Shiga toxin in rabbits: kinetics of the initial mucosal immune response and inhibition of toxicity in vitro and in vivo.
    Keren DF; Brown JE; McDonald RA; Wassef JS
    Infect Immun; 1989 Jul; 57(7):1885-9. PubMed ID: 2659525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.